跳至主要内容
临床试验/NCT01991119
NCT01991119已完成不适用

Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation After DC Cardioversion

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 98 人开始时间: 2011年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
98
试验地点
1
主要终点
recurrence of atrial fibrillation

研究概览

简要总结

the purpose of this study is to compare the ability of propafenone and dronedarone to maintain sinus rhythm after DC cardioversion

详细描述

Atrial fibrillation is the most common arrhythmia requiring continuous therapy. Conversion to and maintenance of sinus rhythm is important. Propafenone and dronedarone has been used as treatment for maintenance of sinus rhythm after DC cardioversion. But there are no direct comparison study.

The purpose of this study is to compare the ability of propafenone and dronedarone to maintain sinus rhythm after DC cardioversion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • a patient with persistent atrial fibrillation who received successful DC cardioversion

排除标准

  • prior amiodarone use
  • NYHA class III or IV heart failure
  • Left ventricular ejection fraction < 35%
  • second or third AV block
  • sick sinus syndrome
  • heart rate < 50 beat per minute
  • myocardiac infarction within 3 months
  • pregnant women
  • severe hepatic dysfunction
  • QT prolongation > 500ms or PR interval > 180ms
  • history of hypersensitivity for drug

研究组 & 干预措施

Propafenone

Active Comparator

Propafenone group

干预措施: Propafenone (Drug)

Dronedarone

Active Comparator

Dronedarone group

干预措施: Dronedarone (Drug)

结局指标

主要结局

recurrence of atrial fibrillation

时间窗: 6 month

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Young Keun On

Principle investigator

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验